Amylyx Pharmaceuticals, Inc. (AMLX)
14.01
-0.01
(-0.07%)
USD |
NASDAQ |
Feb 20, 16:00
14.01
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals EPS Diluted (Quarterly) : -0.3684 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Cytokinetics, Inc. | -2.552 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| MediciNova, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.39M |
| Total Expenses (Quarterly) | 34.39M |
| Enterprise Value | 1.201B |
| Earnings Yield | -12.85% |
| Normalized Earnings Yield | -12.85 |